E-drug: Pharmaceuticals and the Developing World
---------------------------------------------
The Ip-health mailing list has provided this reference. The article is a
thorough review from an economist's standpoint about pharmaceuticals
in developing countries,
The latest issue of the Journal of Economic Perspectives contains
an interesting overview article:
Pharmaceuticals and the Developing World
Michael Kremer
Journal of Economic Perspectives Volume 16, Number 4
[...]
The controversy over intellectual property rights for
pharmaceuticals and access to antiretroviral therapies
in developing countries has been the subject of much public
debate recently. This article provides a broader context
for the debate. It first reviews characteristics of the
developing country market for pharmaceuticals, including
small markets, distinct disease environments and weak health
care and regulatory systems. It then outlines key market and
government failures.
A copy of the article is temporarily available for review and
criticism at:
http://www.gricf.org/kremer.pdf
Richard Laing
Boston University School of Public Health
richardl@bu.edu
[If you are unable to access this document on the website please
contact e-drug and we can send a pdf copy directly to you. BS]
--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@usa.healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug